New Wave. Erik Engellau (Norrsken Launcher): How To Commercialize Science
35 snips
Jan 6, 2026 In this engaging conversation, Erik Engellau-Nilsson, Founder of Norrsken Launcher and expert in commercializing deep tech, dives into why groundbreaking science often stays locked in academia. He discusses the cultural chasm between scientists and entrepreneurs and emphasizes the need for hands-on support in building companies. Erik also breaks down the challenges of transforming patents into profits in Europe, highlights effective traits of successful entrepreneurs, and argues for cleaner cap tables to attract better funding. His insights on scaling climate innovations are particularly thought-provoking.
AI Snips
Chapters
Books
Transcript
Episode notes
Culture Gap Between Science And Startups
- Scientists and company builders have fundamentally different incentives and mindsets that make switching roles hard.
- Erik Engellau-Nilsson says successful commercialization needs either scientists who adapt or operators to work alongside them.
Scaling PCR Testing During COVID
- During COVID, Launcher scaled a PCR testing business by automating labs and recruiting Klarna engineers.
- The business grew rapidly to large revenues and profits after Launcher became operationally involved.
Require Industrial Buyer Validation
- Only invest when industrial buyers have validated the technology and signalled willingness to buy at scale.
- Focus on taking commercial and market risk, not primary technical risk, per Erik's Launcher model.
